logo
Sign in

ATTAGENE, INC.

Clean tech · Still private

WASANET, a two-tier water bioactivity surveillance system using the FACTORIAL transcription factor assay platform to detect chemical contaminants and their synergistic effects in water

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Clean tech
Total capital
$8M
Federal grants
$8M
9 awards · 2017–2025
Rank in peer group#1 of 32
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
14 pending · first 2020
Rank in peer group#8 of 32

Capital timeline

20172019202120232025FEDERAL ↑EQUITY ↓Cumulative $8M$1M$1M$1.0M$1M$1M$1.0M
20172019202120232025FEDERAL ↑EQUITY ↓Cumulative $8M$1M$1M$1M$1M

Latest events

  • Federal grantHealth and Human S · Phase II · A Two-Tier Effect-Based Water Bioactivity Surveillance System.$1.0M
  • Federal grantHealth and Human S · Phase II · Assigning mode of action to phenotypically discovered anticancer leads.$1M
  • Federal grantHealth and Human S · Phase II · Assigning mode of action to phenotypically discovered anticancer leads.$1M
  • Federal grantHealth and Human S · Phase II · Assessing the polypharmacology of kinase inhibitors by transcription factor activity profiling$1.0M
  • Federal grantHealth and Human S · Phase II · Assessing the polypharmacology of kinase inhibitors by transcription factor activity profiling$1.0M
  • Federal grantHealth and Human S · Phase II · Predicting DILI liability by transcription factor profiling$707K
  • Federal grantHealth and Human S · Phase II · Predicting DILI liability by transcription factor profiling$242K
Show 2 earlier federal awards
  • Federal grantHealth and Human S · Phase II · Predicting DILI liability by transcription factor profiling$1M
  • Federal grantHealth and Human S · Phase II · Predicting DILI liability by transcription factor profiling$1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 32 peers

Line = median

Clean tech · Platform

  • Federal grants#1 · top 3%
  • Granted patents#8 · top 25%
  • Linked publications#2 · top 6%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 15
Show all 15 patent records
  • Nanopore-based Multiplexed Reporter Assay System And MethodFeb 19, 2026 · Application 19104411Pending
  • Method For Identification Of Perturbagens Of Particular Biological Processes And Cell Systems Within Living CellsJun 17, 2021 · Application 17270005Pending
  • Multiplexing Transcription Factor Reporter Protein Assay Process And SystemJan 28, 2020 · US 10,544,472Granted
  • Method For Identification Of Perturbagens Of Particular Biological Processes And Cell Systems Within Living CellsApplication PCTUS2019047365Pending
  • Evaluating Biological Activity Of Compounds By Transcription Factor Activity ProfilingApplication 62720049Pending
  • Multiplexing Transcription Factor Reporter Protein Assay Process And SystemApplication PCTUS2015010724Pending
  • Multiplexing Transcription Factor Reporter Protein Assay Process And SystemApplication 61929043Pending
  • Systems And Methods For Assay Of Bio-contaminants In WaterApplication PCTUS2012054336Pending
  • Systems And Methods For Assessment Of BiosimilarityApplication PCTUS2012054338Pending
  • Modulators Of Tnfa-dependent Signaling Pathways And Uses ThereofApplication PCTUS2009045084Pending
  • Methods And Compositions For Non-invasive Assessment Of Gene ExpressionApplication PCTUS2006038176Pending
  • Methods And Constructs For Analyzing Biological Activities Of Biological Specimens And Determining States Of OrganismApplication PCTUS2006038175Pending
  • Populations Of Reporter Sequences And Methods Of Their UseApplication PCTUS2005041111Pending
  • Nanopore-based Multiplexed Reporter Assay System And MethodApplication PCTUS2023072526Pending
  • Dynamic Real-time Transcription Factor Activity Assay System And MethodApplication 63371808Pending

Recent research by its founders

  • Bioactivity of the ubiquitous tire preservative 6PPD and degradant, 6PPD-quinone in fish- and mammalian-based assays20254 cites
  • The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response20254 cites
  • Moldable Plastics (Polycaprolactone) can be Acutely Toxic to Developing Zebrafish and Activate Nuclear Receptors in Mammalian Cells202415 cites

Related companies, and why

Regulatory activity · Clean tech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .